Bactericidal Activity of a Monoclonal Antibody Against a Recombinant 40-kDa Outer Membrane Protein of Porphyromonas gingivalis

Journal of Periodontology

Volumn 71, Issue 3, 2000, Pages 368-375

  Katoh, Mitsunobu ^b   Saito, Shigeno ^b   Takiguchi, Hisashi ^b   Abiko, Yoshimitsu ^a  

^a NIHON UNIVERSITY   (Japan)

^b NONE

Author keywords

Antibodies, monoclonal; Immunotherapy; Periodontitis therapy; Porphyromonas gingivalis; Recombinant proteins; Vaccines

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; CARBON; COMPLEMENT; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN; RADIOPHARMACEUTICAL AGENT; RECOMBINANT PROTEIN; THYMIDINE; TRITIUM;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; FEMALE; GROWTH, DEVELOPMENT AND AGING; GUINEA PIG; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOLECULAR CLONING; MOUSE; PASSIVE IMMUNIZATION; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; SYNTHESIS; VIRULENCE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CARBON RADIOISOTOPES; CLONING, MOLECULAR; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; FEMALE; GUINEA PIGS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RADIOPHARMACEUTICALS; RECOMBINANT PROTEINS; THYMIDINE; TRITIUM; VIRULENCE;

EID: 0034153214     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.71.3.368     Document Type: Article

References (45)

1. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol 1992;63:322-331.
2. Genco RJ. Host responses in periodontal diseases: Current concepts. J Periodontol 1992;63:338-355.
3. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: A two-way relationship. Ann Periodontol 1998; 3:51-61.
4. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67(Suppl.):1123-1137.
5. Genco RJ. Periodontal disease and risk for myocardial infarction and cardiovascular disease. Cardiovasc Rev Rep 1998;19:34-40.
6. Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996;67(Suppl.):1103-1113.
7. Dasanayake AP. Poor periodontal health of the pregnant woman as a risk factor for low birth weight. Ann Periodontol 1998;3:206-212.
8. Slots J. Importance of black-pigmented Bacteroides in human periodontal disease. In: Genco RJ, Mergenhagen SE, eds. Host-Parasite Interactions in Periodontal Diseases. Washington, DC: ASM Press; 1982:27-45.
9. Slots J, Genco RJ. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: Virulence factors in colonization, survival and tissue destruction. J Dent Res 1984;63:412-421.
10. Socransky SS, Haffajee AD. Microbial mechanisms in the pathogens of destructive periodontal diseases: A critical assessment. J Periodont Res 1991;26:195-212.
11. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
12. Abiko Y, Hayakawa M, Aoki H, Kikuchi T, Shimatake H, Takiguchi H. Cloning of a Bacteroides gingivalis outer membrane protein gene in Escherichia coli. Arch Oral Biol 1990;35:689-695.
13. Kawamoto Y, Hayakawa M, Abiko Y. Purification and immunochemical characterization of a recombinant outer membrane protein from Bacteroides gingivalis. Int J Biochem 1991;23:1053-1061.
14. Hiratsuka K, Yoshida W, Hayakawa M, Takiguchi H, Abiko Y. Polymerase chain reaction and an outer membrane gene probe for the detection of Porphyromonas gingivalis. FEMS Microbiol Lett 1996;138:167-172.
15. Booth V, Ashley FP, Lehner T. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect Immun 1996; 64:422-427.
16. Oishi T, Hayakawa M, Takiguchi H. Monoclonal antibody against Porphyromonas gingivalis 40-kDa outer membrane protein. Nihon Univ J Oral Sci 1994;20:120-128.
17. Wilson ME. The immune system and host defense. In: Nisengard RJ, Newman MG, eds. Oral Microbiology and Immunology, 2nd ed. Philadelphia: Saunders; 1994:8-46.
18. Fine DP. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function. Infect Immun 1977;16:124-128.
19. Eidinger D, Bello E, Mates A. The heterocytotoxicity of human serum. I. Activation of the alternative complement pathway by heterologous target cells. Cell Immunol 1977;29:174-186.
20. Kolb WP, Kolb LM, Podack ER. C1q: Isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay. J Immunol 1979;122:2103-2111.
21. 14C-labeled Neisseria meningitidis. Proc Soc Exp Biol Med 1972;139:1175-1180.
22. Daly C, Mitchell D, Grossberg D, Highfield J, Stewart D. Bacteremia caused by periodontal probing. Aust Dent J 1997;42:77-80.
23. Deshpande RG, Khan MB, Genco CA. Invasion of aorta and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998;66:5337-5343.
24. Saito S, Hayakawa M, Hiratsuka K, Takiguchi H, Abiko Y. Complement-mediated killing of Porphyromonas gingivalis 381 by the immunoglobulin G induced by recombinant 40-kDa outer membrane protein. Biochem Mol Med 1996;58:184-191.
25. Kolenbrander PE, London J. Adhere today, here tomorrow: Oral bacterial adherence. J Bacteriol 1993;175: 3247-3252.
26. Kinder SA, Holt SC. Localization of the Fusobacterium nucleatum T18 adhesin activity mediating coaggregation with Porphyromonas gingivalis T22. J Bacteriol 1993;175:840-850.
27. Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. J Immunol 1983; 131:2570-2575.
28. Taylor PW. Bactericidal and bacteriolytic activity of serum against Gram-negative bacteria. Microbiol Rev 1983; 47:46-83.
29. Kilian M. Degradation of immunoglobulins A1, A2, and G by suspected principal periodontal pathogens. Infect Immun 1981;34:757-765.
30. Sundqvist G, Carlsson J, Herrmann B, Tärnavik A. Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J Med Microbiol 1985;19:85-94.
31. Grenier D, Mayrand D, McBride BC. Further studies on the degradation of immunoglobulins by black-pigmented Bacteroides. Oral Microbiol Immunol 1989;4:12-18.
32. Gregory RL, Kim DE, Kindle JC, Hobbs LC, Lloyd DR. Immunoglobulin-degrading enzymes in localized juvenile periodontitis. J Periodent Res 1992;27:176-183.
33. Grenier D. Inactivation of human serum bactericidal activity by a trypsinlike protease isolated from Porphyromonas gingivalis. Infect Immun 1992;60:1854-1857.
34. Schenkein HA. The effect of periodontal proteolytic Bacteroides species on proteins of the human complement system. J Periodont Res 1988;23:187-192.
35. Schenkein HA. Failure of Bacteroides gingivalis W83 to accumulate bound C3 following opsonization with serum. J Periodont Res 1989;24:20-27.
36. Fletcher HM, Schenkein HA, Morgan RM, Bailey KA, Berry CR, Macrina FL. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect Immun 1995;63:1521-1528.
37. Schenkein HA, Fletcher HM, Bodnar M, Macrina FL. Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins. J Immunol 1995;154:5331-5337.
38. Okuda K, Kato T, Naito Y, Ono M, Kikuchi Y, Takazoe I. Susceptibility of Bacteroides gingivalis to bactericidal activity of human serum. J Dent Res 1986;65:1024-1027.
39. Shillitoe EJ, Lehner T. Immunoglobulins and complement in crevicular fluid, serum and saliva in man. Arch Oral Biol 1972;17:241-247.
40. Attström R, Laurel A-B, Lahsson U, Sjöholm A. Complement factors in gingival crevice material from healthy and inflamed gingiva in humans. J Periodont Res 1975;10:19-27.
41. Schenkein HA, Genco RJ. Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins. J Periodontol 1977;48:772-777.
42. Nisengard R, Jarrett C. Coating of subgingival bacteria with immunoglobulin and complement. J Periodontol 1976;47:518-521.
43. Shibata Y, Hiratsuka K, Takiguchi H, Abiko Y. Recombinant phage antibody against P. gingivalis outer membrane protein. J Dent Res 1995;74(Spec. Issue):974 (Abstr. 52).
44. Saito S, Hiratsuka K, Hayakawa M, Takiguchi H, Abiko Y. Inhibition of a Porphyromonas gingivalis colonizing factor between Actinomyces viscosus ATCC 19246 by monoclonal antibodies against recombinant 40-kDa outer membrane protein. Gen Pharmac 1997;28:675-680.
45. Abiko Y, Ogura N, Matsuda U, Yanagi K, Takiguchi H. A human monoclonal antibody which inhibits the coaggregation activity of Porphyromonas gingivalis. Infect Immun 1997;65:3966-3969.